A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism

Movement Disorders

Volumn 12, Issue 1, 1997, Pages 107-110

  Negrotti, A ^a   Calzetti, S ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Cinnarizine; Drug induced; Flunarizine; Long term outcome; Parkinsonism

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; FLUNARIZINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG ACCUMULATION; DRUG EXPOSURE; ESSENTIAL TREMOR; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; FEMALE; HUMAN; MALE; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS;

AGED; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; CINNARIZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUNARIZINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE, SECONDARY; TREATMENT OUTCOME;

EID: 0031025533     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120119     Document Type: Article

References (11)

1. Michell FE, Fernandez Pardal MM, Giannaula R, et al. Movement disorders and depression due to flunarizine and cinnarizine Mov Disord 1989;4:139-146.
2. Mangone CA, Herskovits E. Extrapyramidal and depressive side reactions with flunarizine and cinarizine [Letter] J Neurol Neurosurg Psychiatry 1989;52:288-289.
3. Garcia Ruiz PJ, Garcia de Yebenes J, Jimenez-Jimenez FJ, Vazquez A, Garcia Urra D, Morales B. Parkinsonism associated with calcium-channel blockers: a prospective follow-up study. Clin Neuropharmacol 1992;15:19-26.
4. Calne DB, Zigmond MJ. Compensatory mechanisms in degenerative neurologic diseases: insights from parkinsonism. Arch Neurol 1981;48:361-363.
5. Baldesserini RJ, Cole JO, Davis JM, et al. Tardive Dyskinesia Task Force Report 18. Washington, DC: American Psychiatric Association, 1981.
6. Melamed E, Achiron A, Shapira A, Davidovicz S. Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome? Clin Neuropharmacol 1991;14:273-278.
7. Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 1988;51:850-854.
8. Negrotti A, Calzetti S, Sasso E. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility. Neurotoxicology 1992;13:261-264.
9. Giménez-Roldàn S, Mateo D. Cinnarizine-induced parkinsonism: susceptibility related to aging and essential tremor. Clin Neuropharmacol 1991;14:156-164.
10. Friedman JH. Drug-induced parkinsonism. In: Lang AE, Weiner WJ, ed. Drug-induced movement disorders. Mount Kisco, NY: Futura Publishing, 1992:41-83.
11. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia [Letter]. Arch Gen Psychiatry 1982;39:486-487.